Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKYA
3951
DELISTED
Akoya BioSciences
AKYA
| $25.4K | ﹤0.01% |
5,455
+1,840
| +51% | +$10.6K |
|
3952
Full House Resorts
FLL
$80.1M
| $25.3K | ﹤0.01% |
5,921
-999
| -14% | -$5.46K |
|
|
SPYM
3953
State Street SPDR Portfolio S&P 500 ETF
SPYM
$161B
| $25.1K | ﹤0.01% |
500
+250
| +100% | +$13.1K |
|
|
PPLT
3954
abrdn Physical Platinum Shares ETF
PPLT
$1.88B
| $25.1K | ﹤0.01% |
3,000
| – | – |
|
3955
AMES National
ATLO
$271M
| $25.1K | ﹤0.01% |
1,511
-202
| -12% | -$3.72K |
|
3956
Shattuck Labs
STTK
$675M
| $25K | ﹤0.01% |
16,471
| – | – |
|
3957
Acme United Corp
ACU
$217M
| $25K | ﹤0.01% |
+837
| New | +$24.1K |
|
3958
Dakota Gold
DC
$608M
| $25K | ﹤0.01% |
9,691
-1,041
| -10% | -$2.96K |
|
|
YSG
3959
Yatsen Holding
YSG
$322M
| $25K | ﹤0.01% |
5,000
| – | – |
|
3960
PDS Biotechnology
PDSB
$38.4M
| $24.8K | ﹤0.01% |
4,914
-657
| -12% | -$3.6K |
|
3961
Atara Biotherapeutics
ATRA
$75.5M
| $24.8K | ﹤0.01% |
669
-745
| -53% | -$33.2K |
|
|
SBDS
3962
DELISTED
Solo Brands Inc
SBDS
| $24.7K | ﹤0.01% |
121
+12
| +11% | +$2.62K |
|
3963
Trump Media & Technology Group
DJT
$2.73B
| $24.6K | ﹤0.01% |
1,500
| – | – |
|
|
FNCB
3964
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $24.5K | ﹤0.01% |
+4,112
| New | +$25K |
|
3965
Takeda Pharmaceutical
TAK
$54.6B
| $24.4K | ﹤0.01% |
1,580
-50,256
| -97% | -$778K |
|
|
KYNB
3966
Kyntra Bio
KYNB
$27.2M
| $24.4K | ﹤0.01% |
1,132
-6,498
| -85% | -$255K |
|
3967
QuickLogic
QUIK
$232M
| $24.3K | ﹤0.01% |
+2,829
| New | +$23.8K |
|
|
SBT
3968
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $24.2K | ﹤0.01% |
4,147
-294
| -7% | -$1.72K |
|
3969
OP Bancorp
OPBK
$232M
| $24.1K | ﹤0.01% |
+2,631
| New | +$24.7K |
|
3970
Cadiz
CDZI
$251M
| $23.9K | ﹤0.01% |
7,225
-862
| -11% | -$3.3K |
|
3971
DLH Holdings
DLHC
$70.7M
| $23.9K | ﹤0.01% |
+2,044
| New | +$22.2K |
|
|
MCHB
3972
Mechanics Bancorp
MCHB
$3.72B
| $23.6K | ﹤0.01% |
3,032
-3,917
| -56% | -$34.8K |
|
3973
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.72B
| $23.5K | ﹤0.01% |
300
| – | – |
|
3974
TELA Bio
TELA
$32.7M
| $23.4K | ﹤0.01% |
2,929
-246
| -8% | -$2.29K |
|
3975
Primis Financial Corp
FRST
$399M
| $23.4K | ﹤0.01% |
2,865
-2,810
| -50% | -$24.8K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.